Brief: Greenwich LifeSciences Provides Financing Strategy & Corporate Update

Greenwich Lifesciences

28/07/2022 11:03

July 28 (Reuters) - Greenwich Lifesciences Inc  GLSI.O :
    * GREENWICH LIFESCIENCES - BELIEVE CO IS WELL CAPITALIZED
WITH
CASH BALANCE REPORTED ON CO'S FORM 10-Q FOR PERIOD ENDING MARCH
31, 2022 OF $19.7 MILLION
    * GREENWICH LIFESCIENCES INC - COMMENCEMENT OF PHASE III
CLINICAL
TRIAL, FLAMINGO-01, IS EXPECTED TO INCREASE BURN RATE GRADUALLY
OVER TIME
    * GREENWICH LIFESCIENCES INC - INTEND TO USE ATM FACILITY
OPPORTUNISTICALLY IN FUTURE AND DO NOT PRESENTLY INTEND TO USE
FULL AMOUNT OF ATM FACILITY
    * GREENWICH LIFESCIENCES INC - AN UPDATE ON FLAMINGO-01
TRIAL IS
EXPECTED TO BE PROVIDED SHORTLY

Source text for Eikon:  ID:nBw8KKZWRa 
Further company coverage:  GLSI.O 

 ((Reuters.Briefs@thomsonreuters.com;))